Specify a stock or a cryptocurrency in the search bar to get a summary
Celadon Pharmaceuticals PLC
CELCeladon Pharmaceuticals Plc engages in the research, cultivation, manufacturing, and sale of cannabis-based medicines. The company primarily focuses on growing indoor hydroponic cannabis for use in medicinal products. Its products used to treat chronic pain, as well as autism spectrum disorders. Celadon Pharmaceuticals Plc was founded in 2018 and is headquartered in London, the United Kingdom. Address: 32-33 Cowcross Street, London, United Kingdom, EC1M 6DF
Analytics
WallStreet Target Price
18 107.36 GBXP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures CEL
Dividend Analytics CEL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CEL
Stock Valuation CEL
Financials CEL
Results | 2019 | Dynamics |